Most a short while ago, it's been recognized that conolidine and the above derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in similar spots as classical opioid receptors, it binds into a wide array of endogenous opioids. Not like most opioid receptors, this receptor acts being a scavenger and doesn't activate a 2nd messenger